Rate My Professor Stefan Gabrielson

Stefan Gabrielson, MD, PhD, serves as a Senior Lecturer and Consultant Radiologist and Nuclear Medicine specialist in the Department of Pathology and Biomedical Science at the University of Otago, Christchurch, Faculty of Medicine. He earned his medical degree from Linköping University, Sweden, in 2008. He completed specialty training in Radiology and Nuclear Medicine at Karolinska University Hospital, Stockholm, Sweden, from 2011 to 2018. In 2019, he received his PhD in Medical Science from Karolinska Institutet, with a doctoral thesis titled Utility of hybrid SPECT/CT in sentinel lymph node biopsy. Relocating to Christchurch with his family in 2020, he joined the University of Otago as Senior Lecturer in Radiology. He holds a Research Affiliate position at Karolinska Institutet and practices clinically at Reform Radiology, specializing in oncological and abdominal radiology, PET, and Nuclear Medicine including theranostics.

Gabrielson's research specializations include clinical research in molecular imaging for disease staging and therapy response evaluation using PET and SPECT, theranostics, prostate cancer, and cancer of the oesophagus and gastro-oesophageal junction. His key publications are Li, M. et al. (2025), Deep few-view high-resolution photon-counting CT at halved dose for extremity imaging, IEEE Transactions on Medical Imaging; Jonmarker, O. et al. (2025), Retrospective analysis of [99mTc]Tc-HYNIC-PSMA single photon emission computed tomography CT in patients with prostate cancer, Nuclear Medicine Communications; Tzortzakakis, A. et al. (2022), 99mTc-Sestamibi SPECT/CT and histopathological features of oncocytic renal neoplasia, Scandinavian Journal of Urology & Nephrology; Teiler, J. et al. (2022), 99mTc-HMPAO-WBC SPECT/CT versus 18F-FDG-WBC PET/CT in chronic prosthetic joint infection: A pilot study, Nuclear Medicine Communications; and Jonmarker, O. et al. (2021), Comparison of regularized reconstruction and ordered subset expectation maximization reconstruction in the diagnostics of prostate cancer using digital time-of-flight 68Ga-PSMA-11 PET/CT imaging, Diagnostics.